News
Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...
Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...
5d
Zacks Investment Research on MSNMerck KGaA (MKKGY) Upgraded to Strong Buy: Here's WhyInvestors might want to bet on Merck KGaA (MKKGY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates - ...
The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...
Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...
Merck KGaA is the world's largest still-operating pharma and healthcare company, with a 300+ year history. It has absolutely stellar fundamentals, and what risks do exist are well-covered by the ...
Aside from ongoing debt servicing requirements, Merck KGaA has few demands on its free cash flow (EUR 3 billion in 2022) other than its common stock dividend (EUR 0.2 billion in 2022) and ongoing ...
Kai Beckmann, CEO of Electronics at Merck KGaA, discusses Europe's competitiveness in AI development. Trump admin proposes ...
FRANKFURT, March 7 (Reuters) - Merck KGaA (MRCG.DE) forecast a return to modest operating earnings growth this year but only when adjusted for currency headwinds, citing a gradual recovery in ...
Merck KGaA’s forecast caveat came as the company tallied 5.2 billion euros ($5.41 billion) in first-quarter revenue, signaling a 12.2% increase over the same period in 2021.
Germany’s Merck KGaA said Thursday that it expects a challenging 2023, with adjusted earnings forecast to be stable or decline slightly and a hit from foreign-exchange rates, as it reported a ...
FRANKFURT, Nov 9 (Reuters) - Germany's diversified group Merck KGaA (MRCG.DE) flagged that full-year operating earnings would likely be in the lower half of its target range on weak demand for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results